Medical device company XOR-Labs closes $2.85 mln funding deal
Toronto-based medical device company XOR-Lab Inc has secured $2.85 million in follow-on financing. The round was led by Canadian early-stage investment firm Regenesis LP with participation from the company's existing backers, including Xenios AG and MaRS Innovation. Founded in 2011 as a spin-off from the Toronto General Hospital, XOR-Labs is developing technology that aims to repair previously unusable donor lungs and increase the number available for transplantation. It plans to use the funds raised to further develop its technology. XOR-Labs received a $2.6 million investment from Xenios last year.
22 September 2016•3 mins read
